NCT07338630
Comparison of the Interscalene Block Alone Versus Combined With Superior Truncus Block During Shoulder Surgery in Diaphragmatic Function
At risk: Primary completion moved 1 year 4 months later.
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary completion pushed from Apr 1, 2027 to Aug 1, 2028 Show 4 more changesShow less
- Start date: Apr 1, 2026 to Aug 1, 2027
- Eligibility criteria expanded, about 14 words
- Study completion pushed from Jun 1, 2027 to Dec 1, 2028
- Secondary endpoints: details revised at 4 of 4 entries
- Notable Start date: Jan 1, 2026 to Apr 1, 2026
- Primary completion date: Jan 1, 2027 to Apr 1, 2027
- Minor Study description revisedv3
- Notable Phase: Phase 4 to Not applicable
- Secondary endpoints: details revised at 1 of 4 entries
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Secondary (4)
Arms and interventions
Interscalene block alone, we will inject 20 mL of 0.5 % bupivacaine plus 10 mL of 0.9 % normal saline around brachial plexus in the interscalene site under ultrasonograhy.
1. We will inject 7 mL of 0.5 % bupivacaine plus 3 mL of 0.9 % normal saline ( Total amount 10 ml) around brachial plexus in the interscalene site under ultrasonograhy. 2. Also we will inject 13 mL of 0.5 % bupivacaine plus 7 mL of 0.9 % normal saline ( Total amount 20 ml) around Superior trunk of brachial plexus under ultrasonagraphy.
Other: Regional anesthesia in shoulder surgery